<?xml version="1.0" encoding="UTF-8"?>
<svg height="813.2" width="537.0" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.61,0.61,0.67,0.56,0.33,0.25,0.44,0.5,0.5,0.39,0.5,0.5,0.28,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.5,0.67,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25" y="44.8" x="315.6,321.4,327.2,333.5,338.8,342.0,344.4,348.6,353.3,358.1,361.7,366.5,371.2,373.9,376.3,381.1,385.8,390.6,395.3,398.5,403.2,408.0,411.1,415.9,420.6,425.3,430.1,433.3,438.1,442.8,447.6,452.3,454.7,459.5,461.9,465.0,469.8,474.5,480.8,483.2,488.0,492.8,497.5,502.3,505.4,510.2,514.9,519.7,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">EXCLI Journal 2017;16:1103-1113 – ISSN 1611-2156 </text>
  <text svgx:width="0.61,0.44,0.44,0.44,0.28,0.44,0.44,0.5" y="55.7" x="217.3,223.1,227.3,231.5,235.7,238.4,242.6,246.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Received</text>
  <text svgx:width="0.28" y="55.7" x="251.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.44,0.44,0.5,0.28,0.44,0.5" y="55.7" x="254.2,256.6,260.8,265.5,270.3,274.5,276.9,281.7,286.4,288.8,291.2,295.9,300.7,305.4,310.2,312.6,315.0,319.7,323.9,328.1,332.4,337.1,339.8,344.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> June 26, 2017, accepted</text>
  <text svgx:width="0.28" y="55.7" x="348.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5" y="55.7" x="351.2,353.6,359.4,364.2,368.9,373.7,377.4,380.0,382.4,387.2,391.9,394.3,396.7,401.4,406.2,410.9,415.7,418.0,420.4,425.2,429.9,434.7,437.3,440.0,443.6,448.4,452.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 17, 2017, published</text>
  <text svgx:width="0.28" y="55.7" x="457.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25" y="55.7" x="460.0,462.4,468.2,473.0,477.7,482.5,486.1,488.8,491.2,495.9,500.7,503.1,505.5,510.2,514.9,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 29, 2017 </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.25" y="803.2" x="285.7,291.7,297.7,303.7,309.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1111 </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.72,0.56,0.33,0.5,0.67,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.72,0.56,0.72,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.44,0.33" y="96.1" x="70.9,74.3,80.3,85.6,88.6,90.3,98.9,105.6,109.6,115.7,123.7,126.7,128.3,133.7,139.7,145.7,148.7,150.3,161.0,169.7,176.3,185.0,188.0,189.7,195.7,201.0,204.3,210.3,219.0,224.3,230.3,235.0,238.0,241.0,242.6,249.9,255.9,261.2,265.9,271.2,274.2,275.9,279.9,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the NF-κB and MAPK pathways. These re-</text>
  <text svgx:width="0.39,0.5,0.28,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.33" y="109.9" x="70.9,75.6,81.6,84.9,88.3,93.0,96.0,98.8,103.4,109.4,115.4,121.4,126.8,131.5,134.8,137.8,140.6,143.9,150.0,155.3,158.6,161.6,164.4,167.8,173.8,179.1,182.1,184.9,190.9,196.3,202.3,207.6,210.9,216.9,222.9,232.2,237.5,243.5,246.9,249.9,252.7,258.7,262.7,265.7,268.5,273.2,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">sults suggest that the development of sub-</text>
  <text svgx:width="0.39,0.28,0.44,0.5,0.44,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.33" y="123.7" x="70.9,75.6,78.9,84.3,90.3,95.6,101.0,105.7,108.7,109.8,113.1,119.1,124.5,127.8,130.8,131.9,141.3,147.3,153.3,159.3,162.6,168.0,171.3,176.7,179.7,180.8,184.1,190.0,195.3,198.3,199.5,204.8,210.8,216.8,220.8,226.1,230.8,235.5,238.8,244.8,250.8,253.8,255.0,261.0,264.9,267.9,269.1,275.1,279.1,285.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">stances that modulate the expression of pro-</text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.44,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.25,0.44,0.25,0.78,0.5,0.28,0.44,0.44,0.33" y="137.5" x="70.9,74.3,80.3,84.3,87.6,93.0,102.3,111.6,116.9,120.2,126.3,130.3,136.3,139.1,148.3,153.7,159.7,163.0,168.4,171.7,177.7,181.7,186.4,189.1,194.5,199.8,205.8,208.6,214.6,218.6,224.6,230.5,233.9,239.9,245.2,248.0,253.3,256.0,265.3,271.3,274.6,280.0,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory mediators can provide a molec-</text>
  <text svgx:width="0.5,0.28,0.44,0.33,0.25,0.5,0.44,0.39,0.28,0.39,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.33,0.5,0.5,0.5,0.39,0.25,0.33,0.5,0.33,0.25" y="151.3" x="70.9,76.9,80.3,85.6,89.6,92.8,98.8,104.1,108.7,112.1,116.7,119.9,123.9,129.9,133.9,137.1,143.1,148.4,154.4,159.7,163.1,169.1,175.1,178.4,184.4,190.4,193.6,197.6,203.6,209.6,214.9,218.2,221.6,227.6,233.6,238.9,242.2,245.4,249.4,255.4,261.4,267.4,272.0,275.2,279.2,285.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ular basis for developing functional foods for </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.28,0.39,0.33" y="165.1" x="70.9,74.3,80.3,85.6,88.6,91.6,94.9,98.9,104.3,109.5,112.9,122.1,127.5,133.5,136.8,139.8,142.8,148.8,152.7,155.7,158.7,164.7,170.0,174.0,177.4,183.3,189.3,194.0,197.0,199.9,203.3,209.3,213.3,216.6,222.0,231.3,240.7,246.0,249.4,255.4,259.4,265.4,268.4,271.3,277.3,280.6,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the treatment of various inflammatory dis-</text>
  <text svgx:width="0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.25" y="178.9" x="70.9,76.3,81.6,86.3,91.6,96.3,99.3,102.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">eases. </text>
  <text svgx:width="0.67,0.5,0.56,0.33,0.28,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.56,0.28,0.44,0.39,0.44,0.39,0.28,0.25" y="206.6" x="70.9,78.9,84.9,91.6,95.6,99.0,102.3,107.6,111.0,114.0,119.9,123.9,126.9,130.3,137.0,140.3,145.6,150.3,155.6,160.3,163.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Conflict of interest </text>
  <text svgx:width="0.61,0.5,0.44,0.25,0.44,0.5,0.28,0.5,0.5,0.33,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.28,0.5,0.44,0.5,0.44,0.28,0.44,0.28,0.25" y="220.3" x="88.8,96.1,102.1,107.5,111.3,116.6,122.6,126.0,132.0,138.0,141.9,146.6,150.5,156.5,161.8,167.8,173.1,176.9,182.9,188.9,192.8,198.1,204.1,213.4,219.4,224.8,228.1,231.4,237.4,243.4,247.3,251.3,254.6,260.6,265.9,271.9,277.3,280.6,285.9,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">The authors have no competing financial </text>
  <text svgx:width="0.28,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.44,0.28,0.44,0.33,0.44,0.25,0.25" y="234.1" x="70.9,74.3,80.3,83.6,88.9,92.9,98.3,102.9,106.3,111.0,114.0,117.3,123.3,126.3,132.3,137.6,142.9,146.3,151.6,155.6,160.9,163.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">interests to declare. </text>
  <text svgx:width="0.67,0.44,0.5,0.56,0.5,0.67,0.28,0.44,0.5,0.5,0.78,0.44,0.56,0.28,0.39,0.25" y="261.8" x="70.9,78.9,84.3,90.3,96.9,102.9,110.9,114.3,119.6,125.6,131.6,140.9,146.3,152.9,156.3,160.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Acknowledgments </text>
  <text svgx:width="0.61,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.33,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.5,0.33,0.44,0.44,0.25" y="275.5" x="88.8,96.1,102.1,105.5,110.2,113.2,115.5,124.2,130.2,134.2,140.2,143.2,145.6,154.3,159.6,164.3,167.3,169.7,174.3,180.3,186.3,192.3,198.3,202.3,205.7,211.0,217.0,220.0,222.4,228.4,234.4,237.4,239.8,243.1,249.2,254.5,257.5,259.9,268.5,274.5,278.5,283.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">This work was supported by the Korea </text>
  <text svgx:width="0.67,0.44,0.39,0.28,0.44,0.25,0.55,0.56,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.33,0.67,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25" y="289.3" x="70.9,78.9,84.3,88.9,92.3,97.6,100.6,110.5,117.2,122.5,125.8,131.2,137.2,142.5,147.8,150.8,160.7,164.7,170.7,175.4,178.7,182.1,185.4,191.4,194.8,200.1,203.1,213.0,217.0,225.0,231.0,237.0,243.0,249.0,255.0,259.0,262.0,271.9,277.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Basic Science Institute (C37965) and </text>
  <text svgx:width="0.33,0.67,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.25" y="303.1" x="70.9,74.9,82.9,88.9,94.9,100.9,106.9,112.9,116.9,119.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(C37260). </text>
  <text svgx:width="0.72,0.67,0.61,0.67,0.72,0.67,0.72,0.72,0.67,0.56,0.25" y="330.8" x="139.7,148.3,156.3,163.6,171.7,180.3,188.4,197.0,205.7,213.6,220.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">REFERENCES </text>
  <text svgx:width="0.72,0.28,0.28,0.44,0.28,0.44,0.5,0.25,0.56,0.39,0.25,0.25,0.61,0.5,0.5,0.28,0.28,0.39,0.5,0.25,0.67,0.72,0.25,0.25,0.89,0.44,0.44,0.28,0.39,0.25,0.61,0.72,0.25,0.25,0.56,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.39,0.25" y="348.6" x="70.9,78.1,81.0,83.7,88.2,90.9,95.4,100.4,103.0,108.6,112.5,114.9,117.6,123.7,128.7,133.7,136.5,139.3,143.2,148.2,150.8,157.5,164.7,167.2,169.9,178.8,183.2,187.6,190.4,194.3,196.9,203.1,210.3,212.8,215.4,221.0,226.0,230.4,234.9,237.7,241.0,243.8,248.2,250.8,253.6,258.6,263.7,266.4,271.5,274.3,277.0,282.0,285.4,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Ajizian SJ, English BK, Meals EA. Specific inhibitors </text>
  <text svgx:width="0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.33,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.25" y="360.1" x="70.9,75.9,79.3,81.8,87.3,92.4,97.3,102.4,104.9,110.5,114.8,119.9,124.9,127.4,133.0,137.4,142.5,145.2,148.6,153.0,157.5,162.0,164.7,167.5,172.5,175.3,179.7,183.0,185.5,191.1,195.1,197.8,202.8,207.9,212.3,215.1,218.4,221.7,226.2,231.2,236.2,239.0,243.4,246.1,250.6,255.6,258.1,263.7,268.7,271.5,276.5,281.0,284.9,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of p38 and extracellular signal-regulated kinase </text>
  <text svgx:width="0.78,0.28,0.28,0.5,0.5,0.44,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.39,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.25" y="371.6" x="70.9,78.7,81.4,84.2,89.2,94.2,98.7,103.7,107.1,111.5,116.0,118.8,121.5,126.6,130.9,133.7,138.2,143.2,145.7,151.2,156.3,159.6,164.6,167.3,171.8,174.6,179.6,182.1,187.6,192.6,195.4,200.4,204.8,208.8,213.2,215.7,221.2,226.2,230.7,233.4,238.4,245.6,250.1,255.0,258.9,261.4,267.0,272.0,274.8,279.8,284.3,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mitogen-activated protein kinase pathways block </text>
  <text svgx:width="0.28,0.5,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.78,0.5,0.33,0.25,0.55,0.5,0.44,0.44,0.33,0.5,0.39,0.28,0.39,0.25" y="383.1" x="70.9,73.7,78.7,83.7,88.8,93.2,96.0,101.0,103.8,108.2,110.7,113.5,118.6,121.3,124.1,127.4,130.1,134.6,137.1,140.0,145.0,150.0,152.8,157.8,162.2,164.7,167.6,171.5,176.5,181.5,184.3,189.2,193.7,197.6,202.0,204.5,207.4,211.8,216.8,221.8,224.3,227.2,230.0,235.0,242.7,247.7,251.0,253.6,256.4,261.4,265.9,270.3,273.6,278.6,282.5,285.3,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inducible nitric oxide synthase and tumor necrosis </text>
  <text svgx:width="0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.44,0.44,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.78,0.5,0.33,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25" y="394.6" x="70.9,74.3,78.7,83.2,86.0,91.0,94.3,96.5,100.9,105.4,109.8,114.8,122.5,127.5,130.3,134.7,137.5,140.3,145.3,150.3,152.4,155.2,160.2,162.3,170.0,175.0,178.4,181.2,186.2,190.6,192.7,200.4,204.9,209.3,212.7,217.7,222.7,227.7,232.2,237.2,241.6,245.5,247.6,251.5,254.2,257.0,264.7,269.7,272.5,277.0,279.7,284.2,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">factor accumulation in murine macrophages stimulated </text>
  <text svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.28,0.5,0.5,0.5,0.5,0.28,0.5,0.39,0.44,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.33,0.5,0.44,0.78,0.78,0.44,0.25,0.25,0.55,0.39,0.25" y="406.1" x="70.9,78.2,80.9,83.7,88.7,91.2,96.7,99.5,102.3,107.3,112.3,117.3,122.3,125.1,130.1,134.0,138.4,142.9,147.3,152.3,156.8,160.1,162.8,167.8,172.3,174.8,180.3,184.7,189.7,194.7,197.2,202.6,205.4,210.4,213.2,217.7,221.0,224.3,228.8,232.1,237.1,242.1,245.4,250.5,255.0,262.7,270.4,274.8,277.3,279.8,285.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">with lipopolysaccharide and interferon-gamma. J </text>
  <text svgx:width="0.33,0.5,0.33,0.44,0.44,0.28,0.25,0.72,0.28,0.39,0.25" y="417.6" x="70.9,74.3,79.2,82.6,87.0,91.5,94.3,96.8,104.0,106.8,110.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Infect Dis.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="417.6" x="115.6,120.7,125.6,130.6,135.7,138.4,143.4,148.4,153.5,156.2,161.2,166.2,171.2,174.5,179.5,184.5,187.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1999;179:939-44. </text>
  <text svgx:width="0.67,0.44,0.33,0.5,0.44,0.39,0.25,0.56,0.39,0.25,0.25,0.72,0.44,0.33,0.28,0.5,0.25,0.89,0.25,0.25,0.72,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.33,0.5,0.44,0.5,0.5,0.44,0.67,0.28,0.25,0.44,0.25,0.5,0.28,0.5,0.5,0.28,0.44,0.28,0.25" y="439.1" x="70.9,77.6,82.1,85.4,90.4,94.8,98.7,101.6,107.2,111.1,113.6,116.5,123.7,128.2,131.5,134.3,139.3,142.2,151.1,153.6,156.6,163.8,168.8,173.3,176.1,180.5,185.0,188.3,191.2,194.5,198.9,203.4,206.2,211.2,214.5,217.8,222.8,227.3,232.3,237.3,241.7,248.4,251.1,254.0,258.5,261.4,266.4,269.2,274.2,279.2,282.0,286.4,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal </text>
  <text svgx:width="0.28,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.25" y="450.6" x="70.9,73.7,77.0,81.4,86.5,90.4,94.8,98.1,100.9,105.9,108.7,111.5,116.5,121.5,124.0,124.9,128.2,132.6,137.1,139.8,144.9,148.2,150.7,151.7,154.4,159.4,161.9,162.8,167.2,172.2,175.6,180.5,185.5,188.2,192.6,195.1,196.1,198.8,203.9,207.2,210.0,214.4,222.2,229.9,234.3,237.1,242.1,245.5,250.5,253.0,253.9,258.9,261.7,265.6,270.0,274.5,278.4,282.8,286.7,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">transcription factor in chronic inflammatory diseases. </text>
  <text svgx:width="0.72,0.25,0.61,0.5,0.5,0.28,0.25,0.39,0.25,0.89,0.44,0.5,0.25" y="462.1" x="70.9,78.2,80.7,86.8,91.7,96.8,99.5,102.0,106.0,108.5,117.4,121.7,126.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">N Engl J Med.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="462.1" x="131.8,136.8,141.8,146.8,151.8,154.5,159.5,164.6,169.6,172.3,177.3,182.3,187.3,192.3,195.6,200.6,205.7,208.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1997;336:1066-71. </text>
  <text svgx:width="0.67,0.5,0.44,0.28,0.25,0.55,0.72,0.67,0.25,0.25,0.55,0.61,0.5,0.44,0.5,0.5,0.25,0.55,0.56,0.25,0.25,0.55,0.61,0.44,0.44,0.25,0.55,0.39,0.67,0.25,0.25,0.55,0.72,0.5,0.5,0.44,0.5,0.25,0.55,0.61,0.61,0.25,0.25,0.55,0.61,0.5,0.28,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.33,0.25" y="483.6" x="70.9,77.6,82.6,87.1,89.9,92.4,93.4,100.6,107.3,109.8,112.4,113.4,119.4,124.5,128.9,133.9,138.9,141.4,142.4,148.0,150.5,153.0,154.0,160.1,164.6,169.0,171.5,172.6,176.5,183.1,185.6,188.1,189.1,196.3,201.3,206.3,210.7,215.7,218.2,219.3,225.4,231.5,234.0,236.5,237.5,243.7,248.7,251.5,254.8,259.3,263.7,268.2,271.0,273.7,278.8,281.5,286.0,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Bhat NR, Zhang P, Lee JC, Hogan EL. Extracellular </text>
  <text svgx:width="0.39,0.28,0.5,0.5,0.44,0.28,0.33,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.78,0.28,0.28,0.5,0.5,0.44,0.5,0.33" y="495.1" x="70.9,74.8,77.6,82.6,87.6,92.1,94.9,98.2,101.5,105.9,110.9,116.0,118.7,123.2,125.9,130.3,135.4,137.6,142.6,145.3,150.3,154.8,158.7,163.2,165.4,169.8,174.8,179.8,182.0,187.0,192.0,197.0,199.2,203.1,208.1,213.1,218.1,221.4,226.4,231.4,236.5,240.4,242.5,247.5,250.9,253.1,260.8,263.6,266.4,271.4,276.4,280.9,285.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">signal-regulated kinase and p38 subgroups of mitogen-</text>
  <text svgx:width="0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.5,0.28,0.5,0.44,0.39,0.44,0.39,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.28,0.5,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.25" y="506.6" x="70.9,75.4,79.8,82.6,85.4,90.4,94.9,97.6,102.1,107.1,109.0,114.1,117.4,122.4,125.1,129.6,132.4,137.4,139.3,144.3,147.1,152.1,156.6,160.4,164.9,168.8,170.7,174.0,178.5,183.5,188.5,191.2,195.7,198.4,202.9,204.8,207.6,212.6,217.6,222.7,227.1,229.9,234.9,237.7,242.1,244.0,249.1,251.8,254.5,257.9,260.6,265.1,267.1,272.0,277.1,279.8,284.9,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">activated protein kinases regulate inducible nitric oxide </text>
  <text svgx:width="0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.78,0.5,0.33,0.25,0.55,0.5,0.44,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.33,0.44,0.28,0.5,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.25" y="518.1" x="70.9,74.8,79.8,84.8,87.6,92.6,97.1,101.0,105.5,108.0,114.6,119.0,124.0,128.9,131.4,138.1,140.8,145.9,153.5,158.6,161.9,164.4,171.1,176.1,180.5,184.9,188.2,193.3,197.2,199.9,203.8,206.3,213.0,216.3,220.8,225.2,227.9,233.0,236.3,239.6,244.1,246.8,251.8,256.8,261.2,263.7,270.3,275.4,279.8,284.8,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">synthase and tumor necrosis factor-alpha gene </text>
  <text svgx:width="0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.55,0.5,0.28,0.28,0.44,0.28,0.25" y="529.6" x="70.9,75.4,80.4,85.4,88.8,93.2,97.1,101.1,103.8,108.8,113.8,116.3,122.1,124.9,129.9,132.4,138.2,142.7,147.6,152.7,157.7,160.4,165.4,170.5,173.2,178.2,181.6,185.5,188.2,190.9,198.6,203.6,206.4,210.9,213.6,218.1,223.1,225.6,231.5,236.5,239.8,242.6,250.3,254.8,258.1,263.1,265.6,271.5,276.5,279.3,282.0,286.5,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">expression in endotoxin-stimulated primary glial </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.5,0.33,0.44,0.39,0.25,0.25,0.39,0.25,0.72,0.44,0.5,0.33,0.5,0.39,0.44,0.28,0.25" y="541.1" x="70.9,75.4,80.4,83.1,85.9,90.9,94.3,98.7,102.6,105.1,107.6,111.5,114.0,121.3,125.6,130.6,134.0,139.0,142.9,147.4,150.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">cultures. J Neurosci.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="541.1" x="155.1,160.1,165.1,170.1,175.1,177.8,182.9,187.9,190.6,195.7,200.6,205.6,210.7,214.0,218.9,224.0,226.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1998;18:1633-41. </text>
  <text svgx:width="0.67,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.25,0.25,0.55,0.72,0.44,0.28,0.28,0.44,0.5,0.5,0.28,0.25,0.55,0.72,0.25,0.25,0.55,0.61,0.78,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.61,0.25,0.25,0.55,0.72,0.44,0.5,0.28,0.44,0.33,0.72,0.44,0.5,0.5,0.28,0.25,0.55,0.72,0.67,0.25,0.25" y="562.6" x="70.9,77.6,82.6,87.1,89.9,94.3,99.3,101.9,102.9,110.2,112.7,115.2,116.3,123.5,127.9,130.7,133.5,138.0,143.0,148.0,150.8,153.3,154.4,161.6,164.1,166.7,167.8,173.9,181.6,186.1,191.1,193.9,198.3,201.7,204.2,205.3,211.5,214.0,216.5,217.6,224.8,229.2,234.2,237.0,241.5,244.8,252.0,256.5,261.5,266.5,269.3,271.8,272.9,280.1,286.8,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, </text>
  <text svgx:width="0.67,0.5,0.5,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.89,0.25,0.25,0.55,0.89,0.44,0.5,0.5,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.72,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.25" y="574.1" x="70.9,77.6,82.6,87.7,92.0,97.0,102.1,104.8,109.2,111.7,115.6,124.5,127.0,129.5,133.4,142.3,146.7,151.7,156.7,161.7,166.7,171.2,176.2,179.0,181.5,185.3,192.6,195.1,197.6,201.5,205.9,208.7,211.2,215.1,219.6,222.3,224.8,227.3,231.3,237.4,242.4,246.8,249.3,253.2,257.6,262.6,267.1,274.7,277.5,282.0,286.4,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Rouabhia M, Mahdouani K, et al. The chemical </text>
  <text svgx:width="0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25" y="585.6" x="70.9,75.3,80.4,88.1,93.1,98.1,102.0,104.8,107.6,110.3,115.4,120.4,122.9,123.7,128.1,133.2,138.2,140.7,141.5,146.5,149.3,154.3,157.1,162.1,167.1,169.9,174.3,178.7,181.5,184.0,184.8,189.3,193.7,196.5,199.2,204.3,207.0,209.8,214.8,217.3,218.1,223.2,226.5,229.0,229.9,234.3,237.0,242.1,247.0,251.5,254.0,254.8,259.2,263.1,267.0,271.4,276.5,279.2,282.0,286.4,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">composition and biological activity of clove essential </text>
  <text svgx:width="0.5,0.28,0.28,0.25,0.25,0.55,0.61,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.33,0.56,0.5,0.44,0.28,0.5,0.28,0.5,0.78,0.25,0.55,0.44,0.33,0.5,0.78,0.44,0.28,0.28,0.44,0.5,0.78,0.25,0.55,0.61,0.25,0.25" y="597.1" x="70.9,76.0,78.7,81.5,84.0,86.5,88.0,94.1,99.1,104.1,108.5,113.6,116.3,120.8,123.3,124.8,129.2,133.6,137.0,142.0,147.0,152.0,157.0,162.0,164.8,167.5,172.0,174.7,179.2,181.7,183.2,186.5,192.1,197.0,201.5,204.3,209.3,212.1,217.1,224.8,227.3,228.8,233.2,236.6,241.6,249.3,253.8,256.5,259.3,263.7,268.8,276.5,279.0,280.5,286.6,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">oil, Eugenia caryophyllata (Syzigium aromaticum L. </text>
  <text svgx:width="0.89,0.5,0.33,0.28,0.44,0.44,0.44,0.44,0.44,0.33,0.28,0.25,0.55,0.44,0.25,0.55,0.39,0.5,0.5,0.33,0.28,0.25,0.55,0.33,0.44,0.5,0.28,0.44,0.72,0.25,0.25,0.55,0.56,0.5,0.5,0.28,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.67,0.44,0.39,0.25" y="608.6" x="70.9,79.8,84.8,88.2,90.9,95.4,99.8,104.3,108.7,113.1,116.5,119.3,121.8,123.3,127.7,130.2,131.7,135.6,140.6,145.6,148.9,151.7,154.2,155.7,159.0,163.4,168.4,171.1,175.6,182.8,185.3,187.8,189.3,194.8,199.8,204.9,207.6,212.6,215.4,220.4,224.8,228.1,230.6,232.2,238.8,243.3,247.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Myrtaceae): a short review. Phytother Res.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.25" y="608.6" x="253.7,258.7,263.6,268.7,273.7,276.4,281.5,286.5,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007;21: </text>
  <text svgx:width="0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="620.1" x="70.9,76.0,80.9,85.9,89.3,94.3,96.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">501-6. </text>
  <text svgx:width="0.67,0.5,0.44,0.5,0.25,0.61,0.72,0.25,0.25,0.67,0.28,0.44,0.5,0.44,0.39,0.25,0.72,0.94,0.25,0.25,0.56,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.33,0.5,0.28,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.72,0.72,0.28,0.56,0.72,0.56,0.72,0.25" y="641.6" x="70.9,77.6,82.6,87.1,92.0,94.1,100.2,107.5,109.9,112.0,118.7,121.5,125.9,130.9,135.3,139.2,141.3,148.5,158.0,160.5,162.6,168.1,173.1,175.9,180.3,185.4,188.1,190.9,195.3,198.1,200.2,203.5,208.6,211.3,215.8,217.8,222.8,226.1,228.2,231.0,236.0,240.4,242.5,246.4,253.6,260.9,263.6,269.2,276.4,281.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chan ED, Riches DW. Potential role of the JNK/SAPK </text>
  <text svgx:width="0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.28,0.33,0.44,0.5,0.39,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.72,0.72,0.56,0.25" y="653.1" x="70.9,74.8,77.6,82.6,87.6,92.1,94.8,98.0,100.8,104.1,108.5,113.6,117.4,122.5,127.5,131.9,134.6,137.4,142.4,147.5,150.6,155.6,160.1,162.8,167.8,175.0,179.5,184.5,187.6,190.4,195.4,198.6,201.4,206.4,210.8,214.0,216.7,221.7,226.7,231.8,236.2,239.0,241.8,246.7,251.7,254.9,259.9,263.2,266.4,269.2,276.4,283.6,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">signal transduction pathway in the induction of iNOS </text>
  <text svgx:width="0.5,0.5,0.25,0.61,0.72,0.56,0.33,0.44,0.28,0.5,0.5,0.44,0.25,0.25,0.67,0.28,0.5,0.44,0.5,0.44,0.78,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.39,0.25,0.67,0.44,0.39,0.25,0.67,0.5,0.78,0.78,0.5,0.5,0.25" y="664.6" x="70.9,75.9,80.9,83.4,89.5,96.8,102.3,105.6,110.1,112.9,117.8,122.9,127.3,129.8,132.3,138.9,141.7,146.7,151.2,156.2,160.7,168.3,170.9,177.5,180.3,185.3,190.3,195.3,200.3,204.2,206.7,213.4,217.8,221.7,224.2,230.8,235.9,243.6,251.4,256.4,261.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">by TNF-alpha. Biochem Biophys Res Commun.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.25" y="664.6" x="266.3,271.3,276.4,281.3,286.4,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1998; </text>
  <text svgx:width="0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="676.1" x="70.9,76.0,80.9,86.0,88.7,93.7,98.7,103.7,107.0,112.1,114.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">253:790-6. </text>
  <text svgx:width="0.67,0.5,0.44,0.5,0.25,0.55,0.94,0.25,0.25,0.55,0.72,0.28,0.28,0.28,0.5,0.44,0.5,0.25,0.55,0.72,0.89,0.25,0.25,0.55,0.72,0.44,0.33,0.44,0.5,0.28,0.5,0.28,0.25,0.55,0.33,0.25,0.55,0.72,0.25,0.55,0.33,0.44,0.5,0.28,0.44,0.72,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.25" y="697.6" x="70.9,77.6,82.6,87.1,92.1,94.6,97.7,107.2,109.7,112.2,115.3,122.6,125.3,128.1,130.9,135.9,140.4,145.4,147.9,151.1,158.3,167.1,169.6,172.1,175.3,182.5,186.9,190.3,194.7,199.8,202.5,207.6,210.3,212.8,216.0,219.3,221.8,224.9,232.2,234.7,237.8,241.1,245.6,250.6,253.4,257.8,265.0,267.5,270.7,275.7,279.1,281.6,284.8,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chen W, Viljoen AM. Geraniol - A review of a </text>
  <text svgx:width="0.44,0.5,0.78,0.78,0.44,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.33,0.44,0.5,0.33,0.44,0.5,0.44,0.44,0.25,0.55,0.78,0.44,0.28,0.44,0.33,0.28,0.44,0.28,0.25,0.25,0.55,0.56,0.25,0.55,0.72,0.33,0.33,0.25,0.55,0.39,0.25" y="709.1" x="70.9,75.4,80.4,88.2,96.0,100.4,103.7,108.2,110.9,115.4,118.2,120.9,125.9,128.4,130.7,133.5,141.2,146.2,151.3,154.6,157.4,161.8,166.9,169.6,172.1,174.3,177.6,180.9,185.4,190.4,193.7,198.1,203.2,207.6,212.0,214.5,216.7,224.4,228.8,231.6,236.1,239.4,242.2,246.6,249.4,251.9,254.4,256.6,262.2,264.7,266.8,274.1,277.4,280.7,283.2,285.4,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">commercially important fragrance material. S Afr J </text>
  <text svgx:width="0.67,0.5,0.28,0.44,0.5,0.5,0.25" y="720.6" x="70.9,77.6,82.6,85.4,89.8,94.9,99.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Botany.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="720.6" x="104.8,109.8,114.8,119.8,124.9,127.6,132.6,137.6,140.3,145.4,150.4,155.3,158.7,163.7,168.7,171.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2010;76:643-51. </text>
  <text svgx:width="0.67,0.5,0.5,0.5,0.5,0.25,0.55,0.67,0.56,0.25,0.25,0.55,0.72,0.5,0.44,0.28,0.5,0.39,0.25,0.55,0.33,0.25,0.25,0.55,0.67,0.44,0.5,0.5,0.28,0.25,0.55,0.56,0.25,0.25,0.55,0.56,0.28,0.44,0.28,0.5,0.25,0.55,0.67,0.89,0.25,0.25,0.55,0.72,0.28,0.5,0.44,0.33,0.5,0.33" y="742.1" x="70.9,77.6,82.6,87.6,92.6,97.6,100.1,102.8,109.5,115.0,117.5,120.0,122.6,129.8,134.9,139.3,142.1,147.1,150.9,153.4,156.1,159.4,161.9,164.4,167.1,173.7,178.2,183.2,188.2,190.9,193.4,196.1,201.7,204.1,206.6,209.3,214.8,217.6,222.0,224.8,229.8,232.3,235.0,241.6,250.5,253.0,255.5,258.1,265.3,268.1,273.1,277.6,280.9,285.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chung CP, Avalos I, Raggi P, Stein CM. Athero-</text>
  <text svgx:width="0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.39,0.28,0.5,0.5,0.28,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.33,0.5,0.44,0.5,0.78,0.44,0.28,0.5,0.28,0.5,0.25" y="753.5" x="70.9,74.8,79.2,82.0,86.4,89.8,94.8,98.7,101.4,105.3,107.8,108.7,113.1,118.1,123.1,125.6,126.5,129.2,134.3,137.6,140.4,144.8,152.6,160.3,164.8,167.5,170.3,175.3,180.4,183.1,185.7,186.5,189.3,194.3,198.2,201.0,206.0,211.0,213.8,217.7,220.2,221.0,224.3,227.6,232.6,240.3,242.8,243.7,247.0,252.0,256.5,261.5,269.2,273.6,276.4,281.4,284.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">sclerosis and inflammation: insights from rheumatoid </text>
  <text svgx:width="0.44,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.67,0.28,0.28,0.5,0.25,0.67,0.5,0.44,0.5,0.78,0.44,0.28,0.5,0.28,0.25" y="765.1" x="70.9,75.4,78.7,81.4,86.5,89.8,92.6,95.3,98.1,102.0,104.5,107.0,113.7,116.4,119.2,124.2,126.7,133.3,138.4,142.8,147.8,155.5,160.0,162.7,167.8,170.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">arthritis. Clin Rheumatol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="765.1" x="175.6,180.6,185.6,190.6,195.7,198.4,203.4,208.4,211.1,216.2,221.2,226.1,231.2,234.5,239.5,244.5,247.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007;26:1228-33. </text>
  <text svgx:width="0.5,0.18,0.72,0.28,0.44,0.39,0.39,0.28,0.5,0.25,0.56,0.72,0.25,0.25,0.72,0.39,0.28,0.44,0.5,0.25,0.67,0.25,0.25,0.67,0.28,0.39,0.39,0.5,0.5,0.25,0.39,0.33,0.56,0.25,0.25,0.56,0.44,0.5,0.5,0.28,0.44,0.5,0.44,0.25,0.39,0.72,0.25,0.25,0.72,0.33,0.39,0.28,0.5,0.28,0.25" y="94.3" x="306.1,311.1,312.9,320.1,322.9,327.4,331.3,335.2,338.0,343.0,345.0,350.5,357.7,360.3,362.2,369.4,373.3,376.1,380.5,385.6,387.5,394.2,396.7,398.7,405.4,408.1,412.0,415.9,420.9,425.9,427.9,431.8,435.1,440.7,443.2,445.2,450.8,455.2,460.2,465.2,468.0,472.4,477.4,481.8,483.8,487.7,494.9,497.5,499.4,506.6,510.0,513.9,516.6,521.6,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">d'Alessio PA, Ostan R, Bisson J-F, Schulzke JD, Ursini </text>
  <text svgx:width="0.89,0.72,0.25,0.25,0.55,0.67,0.44,0.5,0.44,0.25,0.55,0.89,0.67,0.25,0.25,0.55,0.72,0.33,0.44,0.28,0.25,0.55,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.61,0.28,0.78,0.5,0.5,0.44,0.5,0.44,0.25" y="105.7" x="306.1,315.0,322.3,324.8,327.3,329.5,336.2,340.6,345.6,350.1,352.6,354.8,363.6,370.3,372.8,375.3,377.5,384.7,388.1,392.6,395.3,397.8,400.1,404.4,409.5,417.2,419.9,425.0,427.8,431.7,434.5,437.8,442.3,445.0,447.8,452.8,457.9,460.4,462.5,467.6,470.9,473.4,475.6,480.6,483.9,490.0,492.8,500.5,505.5,510.6,515.0,520.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MV, Béné MC. Oral administration of d-Limonene </text>
  <text svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.5,0.28,0.44,0.5,0.39,0.25,0.55,0.44,0.5,0.28,0.28,0.33" y="117.2" x="306.1,310.5,315.6,320.6,323.3,326.6,331.7,334.5,338.3,340.8,341.8,344.5,349.5,352.8,355.6,360.0,367.8,375.6,380.1,382.8,385.6,390.6,395.7,398.2,399.1,401.9,406.9,409.4,410.3,413.6,418.0,420.7,423.2,424.1,428.6,433.6,436.4,439.1,441.9,444.7,448.5,451.1,452.0,456.4,461.4,466.4,468.9,469.8,474.9,477.6,481.5,486.6,489.3,493.8,498.8,502.6,505.1,506.1,510.5,515.5,518.3,521.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">controls inflammation in rat colitis and displays anti-</text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.5,0.28,0.44,0.28,0.25,0.55,0.39,0.5,0.5,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25" y="128.7" x="306.1,308.9,313.9,317.2,320.0,324.5,332.3,340.0,344.5,347.3,352.3,355.6,360.6,363.1,366.0,371.0,374.3,379.3,384.3,388.8,392.1,394.9,397.7,402.1,406.0,408.5,411.3,415.8,419.7,422.2,424.9,430.0,432.7,437.2,440.0,442.5,445.3,449.2,454.2,459.2,464.2,467.0,471.4,479.1,483.6,488.6,491.4,495.8,498.6,501.4,506.4,511.4,513.9,516.7,519.4,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory properties as diet supplementation in </text>
  <text svgx:width="0.5,0.5,0.78,0.44,0.5,0.39,0.25,0.25,0.61,0.28,0.33,0.44,0.25,0.56,0.44,0.28,0.25" y="140.2" x="306.1,311.1,316.2,323.8,328.3,333.3,337.2,339.8,342.3,348.4,351.1,354.5,358.9,361.4,367.0,371.4,374.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">humans. Life Sci.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="140.2" x="379.2,384.2,389.2,394.2,399.2,402.0,407.0,412.0,414.8,419.8,424.7,429.8,434.8,438.1,443.1,445.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2013;92:1151-6. </text>
  <text svgx:width="0.56,0.44,0.33,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.61,0.56,0.25,0.25,0.56,0.44,0.39,0.39,0.5,0.39,0.25,0.72,0.56,0.25,0.25,0.89,0.44,0.5,0.44,0.28,0.33,0.5,0.39,0.25,0.67,0.25,0.25,0.5,0.44,0.25,0.67,0.5,0.5,0.5,0.44,0.25,0.56,0.89,0.25,0.25" y="161.7" x="306.1,311.7,316.2,319.5,324.5,329.0,333.9,339.0,343.4,347.3,350.0,356.1,361.7,364.2,366.8,372.4,376.9,380.8,384.7,389.7,393.6,396.3,403.5,409.0,411.6,414.3,423.1,427.5,432.5,437.0,439.8,443.1,448.1,452.0,454.7,461.3,463.9,466.5,471.5,476.0,478.7,485.3,490.3,495.3,500.4,504.8,507.5,513.1,521.9,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Fernandes ES, Passos GF, Medeiros R, da Cunha FM, </text>
  <text svgx:width="0.56,0.44,0.33,0.33,0.44,0.28,0.33,0.44,0.25,0.55,0.39,0.25,0.25,0.55,0.67,0.44,0.78,0.5,0.5,0.39,0.25,0.55,0.89,0.89,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" y="173.2" x="306.1,311.7,316.1,319.4,322.7,327.2,329.9,333.2,337.7,340.2,343.5,347.4,349.9,352.4,355.7,362.4,366.8,374.5,379.5,384.5,388.4,391.0,394.3,403.2,412.0,414.5,417.0,420.4,424.8,427.5,430.0,433.3,437.7,440.5,443.0,445.5,448.8,456.0,461.0,463.8,466.6,469.9,472.7,477.7,481.0,483.8,488.2,496.0,503.8,508.3,511.0,516.1,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Ferreira J, Campos MM, et al. Anti-inflammatory </text>
  <text svgx:width="0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.5,0.5,0.5,0.39,0.25,0.55,0.44,0.28,0.5,0.5,0.44,0.33,0.5,0.5,0.78,0.5,0.28,0.44,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.33,0.33,0.33,0.28,0.33,0.44,0.5,0.39,0.33" y="184.7" x="306.1,310.6,313.9,317.3,321.7,326.2,329.0,332.9,335.4,337.3,342.3,345.6,348.1,350.1,354.5,359.5,367.2,372.3,377.3,382.2,387.3,392.3,396.2,398.7,400.6,405.1,407.8,412.8,417.8,422.3,425.6,430.6,435.6,443.3,448.3,451.1,455.5,460.6,465.0,467.5,469.5,473.9,478.9,483.9,486.4,488.3,491.7,495.0,498.3,501.7,504.4,507.8,512.2,517.2,521.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">effects of compounds alpha-humulene and (-)-trans-</text>
  <text svgx:width="0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.44,0.5,0.44,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.25,0.5,0.33,0.25,0.67,0.5,0.33,0.5,0.28,0.44,0.25" y="196.2" x="306.1,310.6,315.1,318.4,323.4,328.4,333.4,338.4,343.4,346.2,348.9,353.4,358.4,362.9,365.5,368.2,372.1,377.1,379.9,384.4,387.1,391.6,396.6,399.2,402.6,405.9,410.9,418.6,421.2,424.0,429.0,433.5,436.2,440.6,444.5,448.5,452.8,457.9,460.6,463.4,467.8,470.6,473.2,478.3,481.0,483.7,486.4,491.3,494.7,497.3,504.0,509.0,512.3,517.3,520.1,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">caryophyllene isolated from the essential oil of Cordia </text>
  <text svgx:width="0.5,0.44,0.33,0.5,0.44,0.5,0.44,0.44,0.44,0.44,0.25,0.25,0.61,0.5,0.33,0.25,0.39,0.25,0.56,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.28,0.25" y="207.7" x="306.1,311.1,315.6,318.9,323.9,328.3,333.3,337.8,342.2,346.7,351.1,353.6,356.1,362.2,367.2,370.6,373.1,377.0,379.4,385.0,390.0,394.4,397.8,405.4,409.9,414.3,419.3,422.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">verbenacea. Eur J Pharmacol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="207.7" x="427.2,432.2,437.2,442.2,447.2,450.0,455.0,460.0,465.1,467.8,472.8,477.8,482.8,486.1,491.1,496.1,498.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007;569:228-36. </text>
  <text svgx:width="0.56,0.5,0.5,0.39,0.44,0.44,0.44,0.25,0.72,0.72,0.25,0.25,0.56,0.44,0.28,0.5,0.44,0.5,0.5,0.25,0.56,0.67,0.25,0.25,0.5,0.44,0.25,0.55,0.67,0.44,0.33,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.56,0.61,0.25,0.25,0.55,0.56,0.44,0.28,0.5,0.44,0.5,0.5,0.33,0.28,0.25" y="229.2" x="306.1,311.7,316.7,321.7,325.6,330.1,334.5,339.0,342.2,349.4,356.7,359.2,362.4,368.0,372.4,375.2,380.2,384.7,389.7,394.7,397.9,403.5,410.2,412.7,416.0,421.0,425.4,427.9,428.7,435.4,439.8,443.2,448.2,452.6,455.3,460.4,465.4,467.9,468.7,474.2,480.3,482.8,485.3,486.1,491.7,496.1,498.9,503.9,508.3,513.3,518.3,521.6,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Fonseca DV, Salgado PR, de Carvalho FL, Salvadori </text>
  <text svgx:width="0.89,0.72,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.44,0.25,0.55,0.72,0.67,0.25,0.25,0.55,0.61,0.44,0.28,0.28,0.44,0.25,0.55,0.56,0.67,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.72,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.28,0.28,0.39,0.25" y="240.7" x="306.1,315.0,322.3,324.7,327.2,329.3,334.9,339.3,344.3,349.4,353.7,356.2,358.3,365.5,372.2,374.7,377.2,379.3,385.4,389.9,392.7,395.4,399.9,402.4,404.4,410.0,416.7,419.1,421.6,423.7,428.1,430.9,433.4,435.5,440.0,442.8,445.3,447.8,449.8,457.1,461.5,464.8,469.9,472.6,475.4,480.4,485.4,488.2,490.7,492.8,497.2,502.2,507.2,509.9,514.9,517.7,520.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MG, Penha AR, Leite FC, et al. Nerolidol exhibits </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.28,0.25" y="252.2" x="306.1,310.5,315.6,318.3,321.1,326.1,331.2,335.6,338.4,342.8,347.2,352.3,355.0,357.8,362.8,367.3,369.8,379.7,384.1,389.1,394.1,396.6,406.5,411.0,416.0,418.8,421.5,424.8,427.6,432.6,436.0,438.7,443.1,450.9,458.6,463.1,465.9,470.9,474.2,479.2,481.7,491.6,496.0,500.5,503.2,506.0,511.0,513.8,516.5,521.5,524.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">antinociceptive and anti-inflammatory activity: </text>
  <text svgx:width="0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.72,0.72,0.67,0.72,0.44,0.33,0.5,0.28,0.44,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.5,0.28,0.5,0.33,0.28,0.44,0.78,0.33" y="263.7" x="306.1,308.9,313.9,318.9,323.9,326.7,331.7,336.2,343.9,348.4,353.4,356.1,358.5,363.6,366.9,369.3,372.0,377.1,381.5,383.9,391.1,398.4,405.1,412.3,416.7,420.1,425.1,427.8,432.2,434.6,438.6,443.5,447.5,450.2,454.7,462.4,464.8,469.2,474.2,479.3,481.7,486.7,490.0,495.0,497.7,502.8,506.1,508.9,513.3,521.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">involvement of the GABAergic system and proinflam-</text>
  <text svgx:width="0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.25,0.55,0.56,0.5,0.5,0.5,0.25,0.55,0.67,0.28,0.28,0.5,0.25,0.55,0.56,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.28,0.25" y="275.2" x="306.1,313.9,318.3,321.1,326.1,329.4,334.4,336.9,337.9,342.3,347.3,350.1,355.1,360.2,362.9,367.9,372.3,376.2,378.7,381.2,382.2,387.7,392.7,397.8,402.7,405.2,406.2,412.9,415.6,418.4,423.4,425.9,426.9,432.4,437.5,441.9,445.2,452.9,457.3,461.7,466.8,469.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">matory cytokines. Fund Clin Pharmacol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.33" y="275.2" x="475.5,480.5,485.5,490.5,495.5,498.3,503.3,508.3,511.1,516.1,521.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2016;30:14-</text>
  <text svgx:width="0.5,0.5,0.25,0.25" y="286.7" x="306.1,311.2,316.1,318.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">22. </text>
  <text svgx:width="0.72,0.44,0.78,0.25,0.72,0.33,0.89,0.25,0.25,0.72,0.5,0.25,0.72,0.33,0.39,0.25,0.25,0.56,0.5,0.5,0.5,0.25,0.56,0.33,0.89,0.25,0.25,0.72,0.28,0.78,0.25,0.39,0.25,0.25,0.72,0.28,0.78,0.25,0.72,0.33,0.72,0.25,0.25,0.72,0.5,0.5,0.25" y="308.2" x="306.1,313.4,317.8,325.5,328.3,335.5,338.9,347.8,350.3,353.0,360.2,365.2,368.0,375.2,378.5,382.4,385.0,387.7,393.3,398.2,403.2,408.3,411.0,416.5,419.8,428.7,431.2,434.0,441.2,444.1,451.7,454.5,458.4,460.9,463.7,470.9,473.6,481.3,484.1,491.3,494.7,501.9,504.5,507.2,514.4,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Ham Y-M, Ko Y-J, Song S-M, Kim J, Kim K-N, Yun </text>
  <text svgx:width="0.39,0.33,0.72,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.67,0.5,0.25" y="319.7" x="306.1,310.0,313.3,320.6,323.1,325.6,326.5,331.0,333.8,336.3,337.2,341.7,344.5,346.9,349.5,350.4,357.7,362.7,365.4,368.2,371.5,374.3,379.3,382.7,385.4,389.9,397.7,405.3,409.8,412.6,417.6,421.0,426.0,428.5,429.5,433.9,437.3,440.6,445.0,449.5,452.2,454.7,455.7,460.7,464.0,466.6,467.5,470.3,473.1,475.9,479.7,484.2,489.2,494.3,497.0,499.8,504.9,509.3,511.8,512.8,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">J-H, et al. Anti-inflammatory effect of litsenolide B2 </text>
  <text svgx:width="0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.61,0.28,0.28,0.39,0.44,0.44,0.25,0.28,0.44,0.5,0.5,0.5,0.28,0.44,0.44,0.25,0.33,0.33,0.5,0.28,0.28,0.25,0.5,0.28,0.44,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.72,0.56,0.33" y="331.2" x="306.1,308.9,312.8,317.8,320.6,325.0,327.8,332.3,337.3,339.6,342.9,346.3,351.3,359.0,361.4,367.5,370.3,373.0,376.9,381.4,385.8,388.2,391.0,395.5,400.5,405.5,410.5,413.2,417.7,422.1,424.5,427.8,431.2,436.2,439.0,441.7,444.1,449.1,451.9,456.3,458.7,462.5,467.6,472.6,477.6,480.9,485.3,489.1,493.0,495.8,500.8,505.8,508.2,515.5,521.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">isolated from Litsea japonica fruit via suppressing NF-</text>
  <text svgx:width="0.5,0.67,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.72,0.56,0.72,0.25,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.56,0.56,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25" y="342.7" x="306.1,311.2,317.8,320.3,321.1,325.6,330.6,335.6,338.1,338.9,347.7,355.0,360.5,367.7,371.0,376.0,380.5,383.2,388.2,395.4,399.9,404.9,408.8,411.3,412.1,414.8,419.8,422.3,423.1,429.2,434.8,440.3,443.7,446.4,451.4,456.4,461.4,465.9,470.3,475.3,478.6,485.2,492.4,501.9,506.9,511.9,516.9,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">κB and MAPK pathways in LPS-induced RAW264.7 </text>
  <text svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.39,0.25,0.56,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.56,0.5,0.5,0.5,0.39,0.25" y="354.2" x="306.1,310.5,315.0,317.7,320.5,324.4,326.9,329.4,333.2,335.8,341.3,346.4,351.4,355.8,358.6,361.4,366.4,371.4,375.8,378.6,381.1,386.7,391.7,396.7,401.7,405.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">cells. J Functional Foods.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.25,0.25" y="354.2" x="410.6,415.6,420.6,425.6,430.6,433.4,438.3,443.4,446.1,451.1,456.2,459.5,464.5,467.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2015;13:80-8. </text>
  <text svgx:width="0.72,0.5,0.78,0.78,0.44,0.39,0.25,0.55,0.72,0.94,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.44,0.28,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.55,0.89,0.56,0.25,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.72,0.44,0.5,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.56,0.39,0.25,0.25" y="375.7" x="306.1,313.4,318.4,326.1,333.8,338.3,342.2,344.7,346.0,353.2,362.8,365.2,367.7,369.1,374.7,379.1,384.1,389.1,393.6,396.4,400.8,405.8,410.8,415.8,419.7,424.1,429.1,431.6,433.0,441.9,447.4,450.0,452.5,453.7,458.8,463.1,468.2,470.7,472.0,479.3,483.6,488.7,493.1,498.1,500.9,505.3,508.6,511.2,512.5,518.1,522.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Hommes DW, Peppelenbosch MP, van Deventer SJ. </text>
  <text svgx:width="0.89,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.33,0.89,0.72,0.56,0.33,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.25" y="387.2" x="306.1,315.0,317.8,320.5,325.6,330.6,335.1,340.0,342.6,348.5,352.9,357.4,360.1,362.9,367.9,372.4,375.1,379.6,384.6,387.1,393.0,398.0,401.4,406.4,409.2,413.6,416.3,421.3,423.8,429.8,433.2,442.0,449.2,454.8,458.1,460.6,466.6,471.6,474.3,479.3,483.7,487.6,492.0,494.5,500.5,504.4,507.1,512.1,517.2,521.6,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Mitogen activated protein (MAP) kinase signal </text>
  <text svgx:width="0.28,0.33,0.44,0.5,0.39,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" y="398.7" x="306.1,308.9,312.2,316.7,321.7,325.6,330.6,335.7,340.1,342.9,345.7,350.7,355.7,358.2,361.0,366.0,370.5,373.2,378.3,385.5,389.9,394.9,398.8,401.3,404.2,408.7,413.7,418.7,421.2,424.0,429.1,434.1,439.1,443.6,446.3,448.8,451.7,456.2,461.2,464.0,466.8,470.1,472.8,477.8,481.1,483.8,488.3,496.1,503.8,508.3,511.0,516.1,519.4,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">transduction pathways and novel anti-inflammatory </text>
  <text svgx:width="0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.25,0.72,0.5,0.28,0.25" y="410.2" x="306.1,308.9,313.3,316.7,321.7,326.1,328.9,332.8,335.3,337.7,345.0,350.0,352.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">targets. Gut.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="410.2" x="357.8,362.8,367.8,372.8,377.8,380.6,385.6,390.6,393.4,398.3,403.3,408.4,411.7,416.6,421.7,424.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2003;52:144-51. </text>
  <text svgx:width="0.72,0.5,0.5,0.5,0.25,0.55,0.72,0.33,0.72,0.25,0.25,0.55,0.72,0.5,0.5,0.5,0.25,0.55,0.94,0.33,0.39,0.25,0.25,0.55,0.72,0.28,0.78,0.25,0.55,0.72,0.72,0.25,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.61,0.33,0.56,0.25,0.25,0.55,0.39,0.5,0.25,0.55,0.56,0.33,0.72,0.25,0.25" y="431.7" x="306.1,313.4,318.4,323.3,328.4,330.9,332.5,339.8,343.1,350.3,352.8,355.3,356.9,364.1,369.2,374.2,379.1,381.6,383.3,392.8,396.1,400.0,402.5,405.0,406.6,413.9,416.6,424.4,426.9,428.6,435.8,443.1,445.5,448.0,449.7,456.9,461.9,466.9,469.4,471.1,477.2,480.5,486.0,488.5,491.0,492.7,496.6,501.5,504.1,505.7,511.3,514.6,521.8,524.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Hong H-K, Yoon W-J, Kim YH, Yoo E-S, Jo S-H. </text>
  <text svgx:width="0.33,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.5,0.78,0.44,0.5,0.25,0.55,0.61,0.28,0.5,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.33,0.5,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.44,0.5,0.44,0.25" y="443.2" x="306.1,309.4,314.4,319.5,322.2,327.3,330.1,332.8,335.6,340.6,345.6,348.1,349.8,354.9,358.2,360.7,362.4,365.1,370.2,374.6,377.1,378.8,386.0,391.1,398.8,403.2,408.2,410.7,412.5,418.6,421.4,426.4,430.8,434.1,437.5,441.9,445.2,450.2,455.3,458.6,463.6,468.6,471.9,475.2,479.7,482.4,486.9,489.7,494.1,499.1,501.6,503.3,510.6,515.0,520.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Inhibition of the Human Ether-a-go-go-related Gene </text>
  <text svgx:width="0.33,0.72,0.61,0.67,0.72,0.33,0.25,0.55,0.72,0.33,0.56,0.33,0.25,0.55,0.67,0.5,0.44,0.5,0.5,0.44,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.61,0.28,0.5,0.5,0.44,0.33,0.44,0.25,0.55,0.44,0.33,0.5,0.28,0.5,0.33,0.5,0.44,0.44,0.33,0.5,0.44,0.25,0.25,0.55,0.39,0.25" y="454.7" x="306.1,309.5,316.7,322.8,329.4,336.7,340.0,342.5,344.9,352.2,355.5,361.1,364.4,366.9,369.4,376.0,381.1,385.4,390.4,395.4,399.9,402.7,406.6,409.1,411.5,416.5,421.4,423.9,426.4,432.5,435.3,440.3,445.3,449.8,453.1,457.5,460.0,462.5,466.9,470.3,475.2,478.0,483.0,486.3,491.3,495.8,500.2,503.5,508.6,513.0,515.5,518.0,520.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(HERG) K(+) Channels by Lindera erythrocarpa. J </text>
  <text svgx:width="0.72,0.5,0.33,0.44,0.44,0.5,0.25,0.89,0.44,0.5,0.25,0.56,0.44,0.28,0.25" y="466.2" x="306.1,313.4,318.3,321.7,326.1,330.5,335.6,338.1,347.0,351.4,356.4,358.9,364.4,368.9,371.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Korean Med Sci.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="466.2" x="376.7,381.7,386.7,391.7,396.7,399.5,404.4,409.5,412.2,417.2,422.2,427.2,432.2,435.5,440.6,445.5,448.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2009;24:1089-98. </text>
  <text svgx:width="0.72,0.39,0.28,0.44,0.5,0.25,0.33,0.72,0.25,0.25,0.67,0.5,0.44,0.5,0.5,0.25,0.72,0.56,0.25,0.25,0.61,0.44,0.5,0.5,0.25,0.67,0.89,0.25,0.25,0.67,0.5,0.44,0.5,0.25,0.67,0.67,0.25,0.25,0.72,0.44,0.5,0.5,0.25,0.67,0.67,0.25,0.25" y="487.7" x="306.1,313.3,317.2,320.0,324.4,329.5,332.5,335.8,343.0,345.5,348.5,355.1,360.2,364.6,369.7,374.7,377.7,384.9,390.5,393.0,396.0,402.1,406.6,411.6,416.6,419.6,426.3,435.2,437.7,440.7,447.4,452.4,456.9,461.9,464.9,471.6,478.2,480.7,483.8,491.0,495.4,500.5,505.5,508.6,515.3,521.9,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Hsieh IN, Chang AS, Teng CM, Chen CC, Yang CR. </text>
  <text svgx:width="0.72,0.44,0.28,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.39,0.25,0.55,0.28,0.28,0.5,0.5,0.5,0.5,0.28,0.5,0.39,0.44,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.33,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25" y="499.2" x="306.1,313.3,317.8,320.5,325.0,330.0,332.8,337.2,340.0,342.7,347.8,350.3,363.3,366.0,371.1,376.1,378.8,383.8,386.6,389.4,393.3,395.8,408.8,411.6,414.3,419.4,424.4,429.4,434.5,437.2,442.2,446.1,450.5,455.0,459.4,464.4,468.9,472.2,475.0,480.0,484.4,487.7,495.4,499.8,504.9,507.6,512.1,514.8,519.3,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Aciculatin inhibits lipopolysaccharide-mediated </text>
  <text svgx:width="0.28,0.5,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.44,0.33,0.5,0.25" y="510.7" x="306.1,308.9,313.9,318.9,323.9,328.4,331.1,336.2,338.9,343.4,345.9,346.7,351.7,354.5,357.2,360.6,363.3,367.7,370.2,371.1,376.1,381.1,383.9,388.9,393.3,395.8,396.7,400.6,405.6,410.6,413.3,418.3,422.7,426.6,431.0,433.5,434.4,438.8,443.8,448.8,451.3,452.1,456.6,461.5,466.0,468.7,473.8,478.8,483.7,488.7,493.8,498.2,503.2,507.7,511.5,516.0,519.3,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inducible nitric oxide synthase and cyclooxygenase-2 </text>
  <text svgx:width="0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.72,0.56,0.33,0.5,0.44,0.5,0.5,0.44,0.67,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.72,0.72,0.28,0.5,0.5,0.5,0.25" y="522.2" x="306.1,310.6,315.6,320.6,323.9,328.4,332.3,336.2,338.9,344.0,349.0,351.5,352.7,357.7,360.5,364.9,367.4,368.7,372.6,377.6,382.6,387.6,390.9,395.4,399.3,403.2,405.9,410.9,416.0,418.5,419.7,426.9,432.5,435.8,440.9,445.2,450.3,455.3,459.7,466.4,468.9,470.1,474.6,479.6,484.6,487.1,488.4,492.2,499.5,506.7,509.4,514.5,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">expression via suppressing NF-kappaB and JNK/p38 </text>
  <text svgx:width="0.89,0.72,0.56,0.72,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.39,0.25,0.25,0.55,0.39,0.25,0.55,0.67,0.28,0.5,0.78,0.44,0.5,0.25,0.55,0.56,0.44,0.28,0.25" y="533.7" x="306.1,315.0,322.2,327.8,335.0,337.5,338.9,343.3,347.8,350.6,353.3,358.4,362.8,365.5,368.3,373.3,378.4,380.9,382.2,387.2,391.7,394.4,399.4,406.7,411.1,416.1,420.0,422.5,425.0,426.3,430.2,432.7,434.1,440.8,443.5,448.6,456.3,460.7,465.7,468.2,469.6,475.2,479.6,482.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MAPK activation pathways. J Biomed Sci.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28" y="533.7" x="488.8,493.7,498.8,503.8,508.8,511.6,516.5,521.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2011;18:</text>
  <text svgx:width="0.5,0.5,0.25,0.25" y="545.2" x="306.1,311.2,316.1,318.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">28. </text>
  <text svgx:width="0.72,0.39,0.28,0.44,0.5,0.25,0.55,0.72,0.72,0.25,0.25,0.55,0.94,0.44,0.5,0.5,0.25,0.55,0.56,0.72,0.25,0.25,0.55,0.61,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.61,0.28,0.5,0.5,0.44,0.33,0.44,0.25" y="566.7" x="306.1,313.4,317.3,320.0,324.5,329.4,331.9,337.9,345.1,352.4,354.8,357.3,363.2,372.7,377.2,382.1,387.1,389.6,395.6,401.1,408.4,410.9,413.4,419.3,425.4,430.4,434.8,437.6,442.6,447.6,452.6,457.0,459.5,465.4,468.8,472.1,477.1,484.7,487.2,493.2,499.3,502.1,507.1,512.1,516.6,519.9,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Hsieh YH, Wang SY. Lucidone from Lindera </text>
  <text svgx:width="0.44,0.33,0.5,0.28,0.5,0.33,0.5,0.44,0.44,0.33,0.5,0.44,0.25,0.89,0.44,0.5,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.28,0.28,0.39,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.39,0.25,0.44,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.39,0.25,0.28,0.5,0.25" y="578.2" x="306.1,310.6,313.9,318.9,321.7,326.7,330.0,335.0,339.5,344.0,347.3,352.3,356.7,359.3,368.2,372.6,377.7,380.4,385.4,390.5,393.1,396.5,399.8,404.8,407.5,410.3,414.2,416.8,420.7,425.7,430.7,435.7,439.1,443.5,447.4,451.3,455.8,459.6,462.3,466.8,471.8,474.5,479.5,484.5,489.5,493.9,498.9,503.4,507.3,510.1,514.0,516.7,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">erythrocarpa Makino fruits suppresses adipogenesis in </text>
  <text svgx:width="0.5,0.61,0.5,0.33,0.61,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.44,0.5,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25" y="589.7" x="306.1,311.1,317.2,322.2,325.6,331.6,336.7,339.2,341.1,345.6,350.0,352.8,355.6,359.5,362.0,363.9,368.4,373.4,378.4,380.9,382.9,387.3,390.1,392.8,397.3,402.3,407.3,411.8,414.5,419.0,422.8,425.3,427.3,432.3,437.3,441.8,445.7,448.5,451.2,456.2,458.7,460.6,465.1,470.1,475.1,477.6,479.5,483.9,489.0,494.0,497.8,502.3,507.3,512.3,516.7,521.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">3T3-L1 cells and attenuates obesity and consequent </text>
  <text svgx:width="0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.33,0.33,0.44,0.28,0.25,0.55,0.5,0.28,0.44,0.28,0.25,0.55,0.67,0.5,0.5,0.67,0.61,0.28,0.5,0.25,0.55,0.78,0.28,0.44,0.44,0.25,0.25" y="601.2" x="306.1,313.9,318.3,321.1,325.5,330.5,335.6,338.3,341.1,345.5,348.0,350.3,355.4,358.1,362.0,367.0,370.3,375.3,379.7,383.1,387.0,389.5,391.8,394.5,399.5,402.1,404.3,409.3,412.0,417.1,422.0,425.3,428.7,433.2,435.9,438.4,440.7,445.7,448.5,452.9,455.7,458.2,460.5,467.2,472.1,477.2,483.8,489.9,492.7,497.7,500.2,502.5,510.2,513.0,517.4,521.9,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">metabolic disorders in high-fat diet C57BL/6 mice. </text>
  <text svgx:width="0.56,0.5,0.5,0.28,0.5,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25" y="612.7" x="306.1,311.7,316.7,321.7,324.5,329.5,337.2,341.6,346.7,349.5,353.9,356.7,361.7,366.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Phytomedicine.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.25,0.25" y="612.7" x="371.2,376.1,381.1,386.2,391.2,393.9,398.9,404.0,406.7,411.7,416.7,421.7,425.0,430.0,435.0,440.0,442.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2013;20:394-400. </text>
  <text svgx:width="0.72,0.72,0.44,0.5,0.5,0.25,0.55,0.61,0.33,0.25,0.25,0.55,0.61,0.44,0.44,0.25,0.55,0.72,0.89,0.25,0.25,0.55,0.61,0.44,0.44,0.25,0.55,0.56,0.89,0.25,0.25,0.55,0.72,0.44,0.5,0.25,0.55,0.94,0.72,0.25,0.25,0.55,0.89,0.5,0.5,0.5,0.25,0.55,0.39,0.56,0.25,0.25" y="634.2" x="306.1,313.4,320.6,325.0,330.0,335.0,337.5,339.5,345.6,348.9,351.4,353.9,355.9,362.0,366.4,370.9,373.4,375.4,382.6,391.5,394.0,396.5,398.5,404.6,409.1,413.4,415.9,417.9,423.5,432.3,434.9,437.4,439.4,446.6,451.0,456.0,458.5,460.4,469.9,477.1,479.6,482.1,484.0,492.9,497.9,502.9,508.0,510.5,512.5,516.3,521.9,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Hwang EI, Lee YM, Lee SM, Yeo WH, Moon JS, </text>
  <text svgx:width="0.72,0.44,0.5,0.5,0.25,0.55,0.61,0.72,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.33,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.5,0.25,0.55,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.5,0.25,0.55,0.44,0.5,0.5,0.25" y="645.7" x="306.1,313.3,317.8,322.8,327.8,330.3,332.2,338.3,345.5,348.0,350.5,352.4,356.8,359.6,362.1,363.9,368.3,371.1,373.6,376.1,378.0,381.3,386.3,391.3,394.1,399.1,401.9,404.7,407.5,412.4,417.5,420.0,421.8,426.8,430.2,432.7,434.6,439.0,444.1,446.8,449.6,452.4,457.4,459.9,461.8,465.7,470.7,475.7,478.4,483.5,487.9,491.8,496.2,498.7,500.5,505.6,508.1,509.9,514.4,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Kang TH, et al. Inhibition of chitin synthase 2 and </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.33,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.5,0.5,0.44,0.5,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.44,0.78,0.25,0.55,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.33,0.25" y="657.2" x="306.1,310.6,315.6,318.4,321.1,324.4,329.4,334.4,339.5,343.9,346.7,349.2,350.9,355.4,359.8,362.6,365.3,370.4,373.1,375.9,380.9,383.4,385.2,390.2,393.5,396.0,397.7,400.5,403.3,408.3,413.3,417.8,422.8,426.6,429.1,430.9,434.2,437.5,442.6,450.3,452.8,454.5,457.3,462.3,466.8,469.3,471.0,474.9,477.7,482.1,489.8,492.3,494.0,499.1,503.5,506.8,511.9,514.4,516.1,521.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">antifungal activity of lignans from the stem bark of </text>
  <text svgx:width="0.61,0.28,0.5,0.5,0.44,0.33,0.44,0.25,0.44,0.33,0.5,0.28,0.5,0.33,0.5,0.44,0.44,0.33,0.5,0.44,0.25,0.25,0.56,0.28,0.44,0.5,0.28,0.44,0.25,0.89,0.44,0.5,0.25" y="668.7" x="306.1,312.3,315.0,320.0,325.1,329.4,332.8,337.3,339.8,344.2,347.5,352.5,355.3,360.3,363.6,368.6,373.1,377.5,380.8,385.9,390.3,392.8,395.3,400.9,403.7,408.1,413.1,415.9,420.3,422.8,431.7,436.1,441.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lindera erythrocarpa. Planta Med.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="668.7" x="446.1,451.1,456.1,461.1,466.1,468.9,473.9,478.9,481.6,486.6,491.6,496.6,500.0,504.9,510.0,512.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007;73:679-82. </text>
  <text svgx:width="0.72,0.44,0.33,0.28,0.5,0.25,0.55,0.89,0.25,0.25,0.55,0.67,0.44,0.5,0.33,0.72,0.44,0.33,0.28,0.44,0.5,0.25,0.55,0.72,0.25,0.25,0.55,0.56,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.44,0.44,0.28,0.39,0.25" y="690.2" x="306.1,313.4,317.8,321.2,323.9,328.9,331.4,336.7,345.6,348.1,350.6,355.9,362.5,366.9,372.0,375.3,382.5,387.0,390.3,393.1,397.5,402.5,405.0,410.3,417.5,420.0,422.5,427.7,433.3,438.3,443.3,447.2,452.2,457.2,462.2,465.6,470.6,473.3,477.8,480.5,483.3,488.3,493.3,495.8,501.1,508.8,513.3,517.7,520.6,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Karin M, Ben-Neriah Y. Phosphorylation meets </text>
  <text svgx:width="0.5,0.5,0.28,0.5,0.5,0.28,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.33,0.33,0.5,0.44,0.5,0.5,0.44,0.33,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25" y="701.7" x="306.1,311.2,316.2,318.9,323.9,329.0,331.7,334.5,337.3,342.3,346.7,349.5,352.2,357.2,362.3,365.0,367.5,370.0,372.7,377.8,382.2,384.7,387.2,391.6,396.6,401.7,404.4,407.7,412.8,415.5,418.0,420.5,425.4,428.8,431.3,433.7,440.9,446.4,449.7,453.1,458.1,462.5,467.5,472.6,477.0,480.2,486.9,489.4,491.9,496.3,500.7,503.5,506.2,511.3,514.0,516.8,521.8,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ubiquitination: the control of NF-[kappa]B activity. </text>
  <text svgx:width="0.72,0.5,0.5,0.5,0.25,0.67,0.44,0.5,0.25,0.33,0.78,0.78,0.5,0.5,0.5,0.28,0.25" y="713.2" x="306.1,313.4,318.4,323.3,328.4,330.9,337.6,341.9,347.0,349.5,352.9,360.5,368.2,373.3,378.3,383.3,386.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Annu Rev Immunol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="713.2" x="391.1,396.1,401.1,406.1,411.2,413.9,418.9,423.9,426.6,431.6,436.7,441.6,445.0,450.0,455.0,457.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2000;18:621-63. </text>
  <text svgx:width="0.72,0.5,0.33,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.67,0.25,0.25,0.55,0.61,0.44,0.5,0.28,0.28,0.25,0.55,0.72,0.25,0.25,0.55,0.72,0.44,0.5,0.5,0.44,0.44,0.5,0.33,0.44,0.5,0.28,0.44,0.25,0.55,0.72,0.25,0.25,0.55,0.89,0.5,0.28,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.61,0.25,0.25" y="734.7" x="306.1,313.4,318.3,321.7,326.7,331.7,336.7,341.1,346.1,348.6,349.8,356.5,359.0,361.5,362.7,368.9,373.3,378.4,381.1,383.9,386.4,387.6,394.9,397.4,399.9,401.0,408.3,412.7,417.7,422.7,427.2,431.6,436.7,440.0,444.4,449.4,452.2,456.6,459.1,460.4,467.6,470.1,472.6,473.8,482.7,487.7,490.5,493.2,497.7,502.7,507.2,512.2,514.7,515.9,522.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Korhonen R, Lahti A, Kankaanranta H, Moilanen E. </text>
  <text svgx:width="0.72,0.28,0.28,0.33,0.28,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.25" y="746.2" x="306.1,313.3,316.1,318.9,322.2,324.9,329.4,331.7,336.7,341.8,344.5,349.5,353.9,356.3,361.3,364.6,369.6,374.6,379.7,384.1,386.9,389.6,394.6,399.6,402.0,406.4,411.4,416.4,418.8,422.7,425.4,430.4,435.4,439.9,442.6,445.4,450.4,455.4,457.8,460.5,465.5,467.9,470.7,475.7,479.0,481.7,486.2,493.9,501.7,506.2,509.0,511.7,516.8,521.8,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Nitric oxide production and signaling in inflammation. </text>
  <text svgx:width="0.67,0.5,0.33,0.33,0.25,0.72,0.33,0.5,0.5,0.25,0.61,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.33,0.5,0.33,0.28,0.44,0.78,0.78,0.25,0.72,0.28,0.28,0.44,0.33,0.5,0.5,0.25" y="757.7" x="306.1,312.8,317.8,321.1,324.5,327.0,334.2,337.5,342.6,347.5,350.1,356.2,360.6,363.9,368.9,373.4,376.1,380.0,382.5,385.8,390.8,394.2,396.9,401.3,409.1,416.9,419.5,426.7,429.5,432.2,436.7,440.0,445.1,450.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Curr Drug Targets Inflamm Allergy.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="757.7" x="455.0,460.0,465.0,470.0,475.1,477.8,482.8,485.6,490.6,495.6,500.6,503.9,508.9,511.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005;4:471-9. </text>
 </g>
</svg>
